Page results
-
This page is designed for patients scheduled to attend our department. It outlines the various tests that may be conducted during your appointment.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
Patient information which describes what miscarriages are, and why they occur, explains what treatment options are available, describes expectant management in detail, explains what can be expected during your recovery from a miscarriage and discusses future pregnancies.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
UCLH is considered a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma.
File results
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers
-
FOI/2023/0849 - Physician Associates
-
FOI/2023/0870 - Cancer treatments cancelled or rescheduled
-
FOI/2023/0874 - Telecommunication infrastructure
-
FOI/2023/0875 - Treatment for bladder cancer